Domestic sales of pharmaceutical products rose by as much as 12.8% in the quarter ended September, market research firm AIOCD Awacs' data showed. Relatively, the sales grew by 9.6% and 6.7% in the March and June quarter, respectively. However, the numbers were affected by the ban on Fixed Dose Combination drugs, whose sales plunged by 16% during the quarter. 